Efficacy and Safety of Ecopipam for Tourette Syndrome (TS): Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial

Category Primary study
Conference2025 International Congress of Parkinson's Disease and Movement Disorders
Year 2025
This article has no abstract
Epistemonikos ID: aaabe5972e568d77ab6a8d6e685cfae2602cb980
First added on: Nov 21, 2025